Live Breaking News & Updates on Prnewswire Ardelyx Inc

Stay updated with breaking news from Prnewswire ardelyx inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative. ....

United States , City Of , United Kingdom , San Francisco , Mike Raab , Clarke Futch , Fosun Pharma , Kyowa Kirin Co Ltd , Japanese Ministry Health , Prnewswire Ardelyx Inc , Healthcare Royalty Management , Ardelyx Inc , Healthcare Royalty Partners , Ardelyx Japanese , Healthcare Royalty , Kyowa Kirin , Knight Therapeutics , Care Royalty ,

Ardelyx to Present at the Jefferies 2022 Healthcare Conference

Press release content from PR Newswire. The AP news staff was not involved in its creation. ....

New York , United States , Mike Raab , Fosun Pharma , Prnewswire Ardelyx Inc , Ardelyx Inc , Jefferies Healthcare Conference , Kyowa Kirin , Knight Therapeutics , Pr Newswire ,

Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults

/PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative. ....

United States , San Diego , Briane Lacy , Fosun Pharma , Prnewswire Ardelyx Inc , Drug Administration , Ardelyx Inc , Disease Week Conference , Poster Presentations , Term Treatment , Tenapanor Improves Abdominal Pain , Treatment Satisfaction , Irritable Bowel Syndrome , Early Onset , Treating Symptoms , Serious Dehydration , Prescribing Information , Boxed Warning , Kyowa Kirin , Knight Therapeutics ,

Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults

Three poster presentations continue to highlight the safety and efficacy of IBSRELA based on data from two Phase 3 trials in adults with irritable. ....

United States , San Diego , Briane Lacy , Fosun Pharma , Exchange Commission , Prnewswire Ardelyx Inc , Exchange Commission On , Drug Administration , Ardelyx Inc , Disease Week Conference , Poster Presentations , Term Treatment , Tenapanor Improves Abdominal Pain , Treatment Satisfaction , Irritable Bowel Syndrome , Early Onset , Treating Symptoms , Serious Dehydration , Prescribing Information , Boxed Warning , Kyowa Kirin , Knight Therapeutics , Private Securities Reform Act , Quarterly Report ,

Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults

Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United States , San Diego , Briane Lacy , Prnewswire Ardelyx Inc , Drug Administration , Disease Week Conference , Poster Presentations , Term Treatment , Tenapanor Improves Abdominal Pain , Treatment Satisfaction , Irritable Bowel Syndrome , Early Onset , Treating Symptoms , Serious Dehydration ,